Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q1 EPS of ($0.72), $0.59 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.